Clinical trial
Brain Penetrance of 2-Hydroxybenzylamine in Humans
NCT03554096 is registered in ClinicalTrials.gov with Metabolic Technologies Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Brain Penetrance of 2-Hydroxybenzylamine in Humans
- Lead sponsor
- Metabolic Technologies Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 23, 2018
- Completion date
- February 8, 2019
- Enrollment
- 3 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy adults